Search
Ascentage Pharma Aims to Issue Up to 22 Million Shares, Seeking to Raise Approximately HK$1.51 Billion
2025-07-15 /
Read about 0 minute
Author：小编
Ascentage Pharma has announced on the Hong Kong Stock Exchange that it has concluded a placement and subscription agreement with the seller and the placement agent. Pursuant to the agreement, the company intends to issue up to 22 million new shares to the seller at a subscription price of HK$68.60 per share, which is equivalent to the placement price. This placement price signifies a discount of roughly 8.17% compared to the closing price of HK$74.70 per share on July 14 on the Hong Kong Stock Exchange. It is anticipated that this subscription will generate approximately HK$1.51 billion in funds.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
